Ospedale San Raffaele S.r.l.;GlaxoSmithKline Biologicals S.A.
发明人:
申请号：
EP17201384.9
公开号：
EP3345617A1
申请日:
2013.11.27
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
An effective Pseudomonas aeruginosa vaccine may require one or several antigenic components, and so various antigens of P. aeruginosa are identified for use in immunisation. These polypeptides may optionally be used in combination with other nosocomial antigens.
